Czech Republic drug consumption, sales

15 January 2001

Drug consumption in the Czech Republic in third-quarter 2000 was worth8.77 billion koruna ($237 million), up 4.4% year-on-year but 9.6% lower than in the previous quarter, reports the State Institute for the Control of Medicines. By defined daily doses, third-quarter consumption fell 0.8% year-on-year to 1,079 per 1,000 of the population, and 11.3% on second-quarter of 2000.

This data is based on distributors' supplies to pharmacies, hospitals and elsewhere, taking account of highest possible profit margins; thus, some analysts believe actual drug spending is about 5% lower.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight